Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Fabio L. L. Mendonça"'
Autor:
Yuri Alves de Oliveira Só, Katyanna Sales Bezerra, Ricardo Gargano, Fabio L. L. Mendonça, Janeusa Trindade Souto, Umberto L. Fulco, Marcelo Lopes Pereira Junior, Luiz Antônio Ribeiro Junior
Publikováno v:
Biomolecules, Vol 14, Iss 7, p 755 (2024)
Exploring therapeutic options is crucial in the ongoing COVID-19 pandemic caused by SARS-CoV-2. Nirmatrelvir, which is a potent inhibitor that targets the SARS-CoV-2 Mpro, shows promise as an antiviral treatment. Additionally, Ivermectin, which is a
Externí odkaz:
https://doaj.org/article/fd223d651df34205a8b42eb607ef7260
Autor:
de Oliveira Só, Yuri Alves1 (AUTHOR) yurialvesy@gmail.com, Bezerra, Katyanna Sales2 (AUTHOR) katy.ksb@gmail.com, Gargano, Ricardo1 (AUTHOR) gargano@unb.br, Mendonça, Fabio L. L.3 (AUTHOR) fabio.mendonca@unb.br, Souto, Janeusa Trindade4 (AUTHOR) janeusatsouto@gmail.com, Fulco, Umberto L.2 (AUTHOR) umberto.laino@ufrn.br, Pereira Junior, Marcelo Lopes3 (AUTHOR) marcelo.lopes@unb.br, Junior, Luiz Antônio Ribeiro1,5 (AUTHOR)
Publikováno v:
Biomolecules (2218-273X). Jul2024, Vol. 14 Issue 7, p755. 12p.